Surmodics Inc
NASDAQ:SRDX
Surmodics Inc
NASDAQ:SRDX
Price:
32.49 USD
-5.96%
Market Closed
Updated:
May 5, 2024
Surmodics Inc
Cash from Operating Activities
|
Surmodics Inc
Cash from Operating Activities Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Surmodics Inc
NASDAQ:SRDX
|
Cash from Operating Activities
$12.5m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-3%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Operating Activities
$3.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Operating Activities
$2.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
40%
|
CAGR 10-Years
8%
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Operating Activities
$3.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Operating Activities
$7.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Operating Activities
$1.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
See Also
What is Surmodics Inc's Cash from Operating Activities?
Cash from Operating Activities
12.5m
USD
12.5m
USD
Based on the financial report for Dec 31, 2023, Surmodics Inc's Cash from Operating Activities amounts to 12.5m USD.
What is Surmodics Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-3%
-3%
The average annual Cash from Operating Activities growth rates for Surmodics Inc have been 6% over the past three years , -15% over the past five years , and -3% over the past ten years .
You don't have any saved screeners yet
